Abbott Laboratories saw the highest growth of 1.64% in patent filings in May and 1.14% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.75% and grants by 1.14%. GlobalData’s DataBook provides a comprehensive analysis of Abbott Laboratories‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Abbott Laboratories has been focused on protecting inventions in United States(US) with 252 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 46% filings and 55% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Abbott Laboratories is filings its patents. Among the top granted patent authorities, Abbott Laboratories has 55% of its grants in United States(US), 21% in European Patent Office(EPO) and 7% in China(CN).
Roche and Samsung Group could be the strongest competitors for Abbott Laboratories
In terms of grant share, Abbott Laboratories stands first among its competitors followed by Roche and Samsung Group.
Patents related to healthtech and remote patient monitoring lead Abbott Laboratories's portfolio
Abbott Laboratories has the highest number of patents in healthtech followed by, remote patient monitoring and smart hospitals. For healthtech, nearly 22% of patents were filed and 34% of patents were granted in Q2 2024.
Cardiovascular devices related patents lead Abbott Laboratories portfolio followed by general surgery devices, and healthcare it
Abbott Laboratories has highest number of patents in cardiovascular devices followed by general surgery devices, healthcare it, other remote patient monitoring, and neurology devices. For cardiovascular devices, nearly 12% of patents were filed and 16% of patents were granted in Q2 2024.
For comprehensive analysis of Abbott Laboratories's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
